Toni Choueiri
http://dbpedia.org/resource/Toni_Choueiri an entity of type: Thing
Toni K. Choueiri is a Lebanese American medical oncologist and researcher. He is the Jerome and Nancy Kohlberg Professor of Medicine at Harvard Medical School and Director of the Lank Center for Genitourinary Oncology at the Dana–Farber Cancer Institute. His work has led to the establishment of several novel drugs (cabozantinib, avelumab, pazopanib and others including combinations) and prognostic factors in advanced renal cell carcinoma (RCC). Choueiri also co-established the International metastatic database Consortium with . His biomarker work has shed light on complex immunogenomics mechanisms contributing to response and resistance to targeted therapy and immunotherapy.
rdf:langString
rdf:langString
Toni Choueiri
rdf:langString
Toni Choueiri
rdf:langString
Toni Choueiri
rdf:langString
Beirut, Lebanon
xsd:integer
66169568
xsd:integer
1064847577
rdf:langString
MD, Saint Joseph University
Residency/Fellowship, Cleveland Clinic
xsd:integer
230
rdf:langString
Toni K. Choueiri is a Lebanese American medical oncologist and researcher. He is the Jerome and Nancy Kohlberg Professor of Medicine at Harvard Medical School and Director of the Lank Center for Genitourinary Oncology at the Dana–Farber Cancer Institute. His work has led to the establishment of several novel drugs (cabozantinib, avelumab, pazopanib and others including combinations) and prognostic factors in advanced renal cell carcinoma (RCC). Choueiri also co-established the International metastatic database Consortium with . His biomarker work has shed light on complex immunogenomics mechanisms contributing to response and resistance to targeted therapy and immunotherapy.
xsd:nonNegativeInteger
15231